Andrew Obenshain, President and CEO at bluebird bio, Inc. (BLUE), sold 7,725 shares at $9.40 ($74K) on 2022-01-10, disclosed to the SEC on 2022-01-12.
Open-market sale of $74k BLUE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.24 | 852 | $8K | 10.7% |
| 2 | $9.40 | 2,190 | $21K | 28.0% |
| 3 | $9.64 | 4,683 | $45K | 61.3% |
| Total | $9.53 avg | 7,725 | $74K | 100% |
| Filing → |
| BLUE | SELL | 2025-01-08 | $1K | — | Filing → |
| BLUE | SELL | 2024-12-12 | $408 | — | Filing → |
| BLUE | SELL | 2024-10-02 | $18K | — | Filing → |